What Does Hims & Hers Health, Inc.'s 14.73% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Suit alleges Hims & Hers Health, Inc. failed to disclose key facts to investors from August 4, 2025 through July 29, 2026; lead plaintiff deadline is November 2, 2026

BENSALEM TOWNSHIP, Pa., Oct. 19, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith today reported that a securities class action lawsuit is pending against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors who acquired its securities from August 4, 2025 through July 29, 2026. The Hims & Hers Health, Inc. case, Velanki v. Hims & Hers Health, Inc., et al., was filed on September 1, 2026 in the U.S. District Court for the Northern District of California (Case No. 3:26-cv-09313).

Investors with losses on Hims & Hers Health, Inc. securities can contact the Law Offices of Howard G. Smith about the Hims & Hers Health, Inc. lawsuit before the November 2, 2026 lead plaintiff deadline.

Key deadlines and dates for Hims & Hers Health, Inc. investors

• Lead plaintiff deadline: November 2, 2026
• Class period: August 4, 2025 through July 29, 2026
• Complaint filed: September 1, 2026

What happened?

On July 29, 2026, the Federal Trade Commission, joined by the State of Utah and Los Angeles County (representing California), filed a federal complaint against Hims & Hers Health in the U.S. District Court for the Northern District of California, alleging deceptive and unlawful privacy practices — including sharing sensitive user health data with third-party advertisers Meta Platforms (Facebook) and Snap via embedded tracking pixels and customer list matching despite marketing emphasizing strict privacy — as well as deceptive billing and subscription-cancellation practices.

On this news, shares of Hims & Hers fell $4.32, or 14.73%, to close at $25.00 per share on July 29, 2026, thereby injuring investors.

What is the Hims & Hers Health, Inc. lawsuit about?

The Hims & Hers Health, Inc. securities lawsuit alleges that, between August 4, 2025 and July 29, 2026, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Hims & Hers Health, Inc.'s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose that: (1) the Company shared consumers' health information with third-party advertising platforms; (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them"; (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result, defendants' positive statements about Hims & Hers Health, Inc.'s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

"The lawsuit against Hims & Hers Health, Inc. alleges that, among other things, the Company failed to tell investors that the Company shared consumers' health information with third-party advertising platforms. Hims & Hers Health, Inc. investors who bought during the class period may be able to pursue their losses, and the November 2, 2026 deadline is where that process begins," said Howard G. Smith of The Law Offices of Howard G. Smith.

Next steps for Hims & Hers Health, Inc. investors

Hims & Hers Health, Inc. investors who suffered losses may contact The Law Offices of Howard G. Smith to learn about pursuing their claims.

Lead plaintiff motions in the Hims & Hers Health, Inc. class action are due to the Court by November 2, 2026. For more information, visit the firm's website, email [email protected], or call (215) 638-4847.

If you purchased Hims & Hers Health, Inc. securities during the class period, you may retain counsel of your choice, or you may take no action and remain an absent class member. No class has been certified in the Hims & Hers Health, Inc. case so far.

Common questions from Hims & Hers Health, Inc. investors

Who is eligible? Investors who acquired Hims & Hers Health, Inc. securities from August 4, 2025 through July 29, 2026 and suffered losses may qualify for the class in the Hims & Hers Health, Inc. shareholder lawsuit.

What is the deadline? Lead plaintiff motions in the Hims & Hers Health, Inc. case are due by November 2, 2026.

Can I recover without being lead plaintiff? Yes, Hims & Hers Health, Inc. investors may take no action and remain absent class members.

Does it cost anything? The Law Offices of Howard G. Smith works on contingency, so investors pay no attorneys' fees unless there is a recovery, and any fees require court approval.

About The Law Offices of Howard G. Smith

The Law Offices of Howard G. Smith has helped injured investors recover their money for more than 15 years. The firm prosecutes securities fraud, takeover, and derivative litigation against public companies and their officers, directors, and advisors in federal and state courts nationwide, and has helped clients recover hundreds of millions of dollars in losses. Clients speak directly with a lawyer, who will promptly answer any question.

Prior results do not guarantee a similar outcome.

Related links

• Hims & Hers Health, Inc. case page, The Law Offices of Howard G. Smith
• Complaint: Velanki v. Hims & Hers Health, Inc., et al., U.S. District Court for the Northern District of California
• FTC complaint
• Hims & Hers Health, Inc. SEC filings index, EDGAR
• The Law Offices of Howard G. Smith

Contact
Howard G. Smith
The Law Offices of Howard G. Smith
3070 Bristol Pike, Suite 112
Bensalem, PA 19020
Email: [email protected]
Telephone: (215) 638-4847
www.howardsmithlaw.com

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE Law Offices of Howard G. Smith